Altimmune, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2010 | $-14.9M | $-15.2M | $374.6K | $2.5M |
| FY2011 | $-7.8M | $-7.9M | $71.4K | $2.6M |
| FY2012 | $-2.3M | $-2.3M | — | $1.9M |
| FY2013 | $-7.2M | $-7.3M | $84.6K | $1.4M |
| FY2014 | $-8.5M | $-8.6M | $92.3K | $1.7M |
| FY2015 | $-3.2M | $-3.3M | $86.5K | $613.0K |
| FY2016 | $-6.4M | $-6.5M | $125.0K | $965.4K |
| FY2017 | $-20.2M | $-20.3M | $112.4K | $1.4M |
| FY2018 | $-9.4M | $-10.4M | $975.4K | $773.2K |
| FY2019 | $-9.6M | $-9.6M | $1.2K | $1.3M |
| FY2020 | $-34.3M | $-34.5M | $204.0K | $2.6M |
| FY2021 | $-78.2M | $-90.4M | $12.1M | $5.5M |
| FY2022 | $-62.6M | $-62.7M | $126.0K | $8.1M |
| FY2023 | $-75.8M | $-75.9M | $47.0K | $10.6M |
| FY2024 | $-79.8M | $-79.8M | — | $14.4M |
| FY2025 | $-67.5M | $-67.5M | $11.0K | $16.1M |